Latest / The Biorevolution Podcast
New tech, new talent, new challenges – pharma leadership in the age of AI
The biorevolution podcast #35
Despite great hopes for Artificial Intelligence (AI) in biotech and pharma—with investments exceeding $50 billion over the past ten years—the question of when the technology will reach maturity remains difficult to answer. How can biotech and pharma leaders navigate this complex gray area, where hype around the technology obscures the outlook and few concrete milestones provide clear signposts for decision-making?
In this episode of the BioRevolution podcast, Louise von Stechow and Andreas Horchler speak with their guest, idalab founder Paul von Bünau, about the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.